Impaired glucose regulation in adults in Jamaica: Who should have the oral glucose tolerance test?

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 16, Issue 1, 2004, Pages 35-42

  Sargeant, Lincoln A ^a   Boyne, Michael S ^a   Bennett, Franklyn I ^a   Forrester, Terrence E ^a   Cooper, Richard S ^b   Wilks, Rainford J ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Blood glucose; Diabetes mellitus; Glucose intolerance; Glucose tolerance test; Jamaica; Mass screening

Indexed keywords

ADULT; DIABETES; GLUCOSE; TOLERANCE;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL PRACTICE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; JAMAICA; KAPPA STATISTICS; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; SYSTOLIC BLOOD PRESSURE; WORLD HEALTH ORGANIZATION; BLOOD; COMPARATIVE STUDY; GLUCOSE TOLERANCE TEST; MASS SCREENING; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE;

ATLANTIC ISLANDS; ATLANTIC OCEAN; CARIBBEAN ISLANDS; GREATER ANTILLES; JAMAICA;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; JAMAICA; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; WORLD HEALTH ORGANIZATION;

EID: 6944222540     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/S1020-49892004000700005     Document Type: Article

References (31)

1. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva: WHO; 1999. (WHO/NCD/NCS/99.2).
2. Shaw JE, Zimmet PZ, de Courten M, Dowse GK, Chitson P, Gareeboo H, et al. Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? Diabetes Care. 1999;22:399-402.
3. de Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouwer CD, et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA. 2001;285:2109-13.
4. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-50.
5. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
6. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 2002;359: 2072-7.
7. Wilks R, Rotimi C, Bennett F, McFarlane-Anderson N, Kaufman JS, Anderson SG, et al. Diabetes in the Caribbean: results of a population survey from Spanish Town, Jamaica. Diabet Med. 1999;16:875-83.
8. Ragoobirsingh D, Lewis-Fuller E, Morrison EY. The Jamaican Diabetes Survey. A protocol for the Caribbean. Diabetes Care. 1995;18: 1277-9.
9. Stern MP, Williams K, Haffner SM. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med. 2002;136:575-81.
10. Ataman SL, Cooper R, Rotimi C, McGee D, Osotimehin B, Kadiri S, et al. Standardization of blood pressure measurement in an international comparative study. J Clin Epidemiol. 1996;49:869-77.
11. Cooper R, Rotimi C, Ataman S, McGee D, Osotimehin B, Kadiri S, et al. The prevalence of hypertension in seven populations of west African origin. Am J Public Health. 1997;87:160-8.
12. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
13. American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-97.
14. Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. BMJ. 1995;311:158-61.
15. United States, Department of Agriculture, Human Nutrition Information Service, Dietary Guidelines Advisory Committee. Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans, 1990. Washington, D.C.: USDA, Department of Health and Human Services; 1990. (USDA Publication No. 261-495/20124).
16. World Health Organization. Diabetes mellitus. Report of a WHO Study Group. Geneva: WHO; 1985. (Technical Report Series 727).
17. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study. Lancet. 1980;1:1373-6.
18. Alberti KG. The clinical implications of impaired glucose tolerance. Diabet Med. 1996;13:927-37.
19. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537-44.
20. de Vegt F, Dekker JM, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ. The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study. Diabetes Care. 1998;21:1686-90.
21. Davies MJ, Raymond NT, Day JL, Hales CN, Burden AC. Impaired glucose tolerance and fasting hyperglycaemia have different characteristics. Diabet Med. 2000;17:433-40.
22. Amoah AG. Undiagnosed diabetes and impaired glucose regulation in adult Ghanaians using the ADA and WHO diagnostic criteria. Acta Diabetol. 2002;39:7-13.
23. Edelstein SL, Knowler WC, Bain RP, Andres R, Barrett-Connor EL, Dowse GK, et al. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes. 1997;46:701-10.
24. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH. The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med. 1988;319:1500-6.
25. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-607.
26. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160-7.
27. Levitt NS, Unwin NC, Bradshaw D, Kitange HM, Mbanya JC, Mollentze WF, et al. Application of the new ADA criteria for the diagnosis of diabetes to population studies in sub-Saharan Africa. American Diabetes Association. Diabet Med. 2000;17:381-5.
28. Mooy JM, Grootenhuis PA, de Vries H, Kostense PJ, Popp-Snijders C, Bouter LM, et al. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia. 1996;39:298-305.
29. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998;21:518-24.
30. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ. 1998;317:371-5.
31. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med. 2002;19:708-23.